Rosa M. Alves
Asst. Dean, Global Compliance, Seton Hall Law School
[email protected]|973-642-8382
PROGRAM SCHEDULED for May 13-15, 2025| Virtual
All times are listed in Eastern Time.
10:50 - 12:05
A Look Inside the Department of Justice’s Evaluation of Effective Compliance Programs Guidance
12:05 - 1:05
Lunch Break
1:05 - 2:25
Implementation of and Demonstrating Adherence to the Guidance
Gary Giampetruzzi
Partner, Litigation Department, Paul Hastings, LLP
Jonathan Mehta
Johnson & Johnson
Joseph Philipose
SVP, Chief Ethics & Compliance Officer, Emergent Biosolutions, Inc.
Keith M. McGahan
Board of Directors, WiNK Therapeutics, Chief Legal Officer, ALG Senior, and General Counsel & Chief Compliance Officer, Nouveau Biosciences
2:25 - 2:40
Break
2:40 - 5:00
Risk Assessment Discussion and Case Study:
9:30 - 11:00
The New Business Ethics and Compliance Function
Piergiorgio Pepe
President, Quantum Ethics
Lawrence Platkin
VP & Head, U.S. Office of Compliance (Retired), Bayer U.S. LLC
Signe Elbaek
Chief Compliance Officer, Mölnlycke Health Care AB (Denmark)
Moderator: Jacob T. Elberg
Professor of Law and Faculty Director, Center for Health & Pharmaceutical Law, Seton Hall Law School
11:00 - 11:15
Break
11:15 - 12:45
12:45 - 1:45
Lunch Break
3:30 - 4:15
Virtual Networking Reception for All Program Faculty & Attendees
10:00 - 11:30
Compliance and Ethical Enterprise Leadership
11:45 - 12:45
Lunch Break
12:45 - 1:45
Deep Dive into Internal Investigations
1:45 - 2:00
Break
3:45 - 4:00
Conclusion & Closing Remarks
